Copyright Reports & Markets. All rights reserved.

Global Venous Leg Ulcers Treatment Market Insights, Forecast to 2025

Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Venous Leg Ulcers Treatment Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Venous Leg Ulcers Treatment Market Size Growth Rate by Product
      • 1.4.2 CureXcell
      • 1.4.3 CVBT-141B
      • 1.4.4 Granexin
      • 1.4.5 HP-802247
      • 1.4.6 Others
    • 1.5 Market by End User
      • 1.5.1 Global Venous Leg Ulcers Treatment Market Size Growth Rate by End User
      • 1.5.2 Hospital
      • 1.5.3 Clinic
      • 1.5.4 Home Use
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Venous Leg Ulcers Treatment Market Size
      • 2.1.1 Global Venous Leg Ulcers Treatment Revenue 2014-2025
      • 2.1.2 Global Venous Leg Ulcers Treatment Sales 2014-2025
    • 2.2 Venous Leg Ulcers Treatment Growth Rate by Regions
      • 2.2.1 Global Venous Leg Ulcers Treatment Sales by Regions
      • 2.2.2 Global Venous Leg Ulcers Treatment Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Venous Leg Ulcers Treatment Sales by Manufacturers
      • 3.1.1 Venous Leg Ulcers Treatment Sales by Manufacturers
      • 3.1.2 Venous Leg Ulcers Treatment Sales Market Share by Manufacturers
      • 3.1.3 Global Venous Leg Ulcers Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Venous Leg Ulcers Treatment Revenue by Manufacturers
      • 3.2.1 Venous Leg Ulcers Treatment Revenue by Manufacturers (2014-2019)
      • 3.2.2 Venous Leg Ulcers Treatment Revenue Share by Manufacturers (2014-2019)
    • 3.3 Venous Leg Ulcers Treatment Price by Manufacturers
    • 3.4 Venous Leg Ulcers Treatment Manufacturing Base Distribution, Product Types
      • 3.4.1 Venous Leg Ulcers Treatment Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Venous Leg Ulcers Treatment Product Type
      • 3.4.3 Date of International Manufacturers Enter into Venous Leg Ulcers Treatment Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Venous Leg Ulcers Treatment Sales by Product
    • 4.2 Global Venous Leg Ulcers Treatment Revenue by Product
    • 4.3 Venous Leg Ulcers Treatment Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Venous Leg Ulcers Treatment Breakdown Data by End User

    6 North America

    • 6.1 North America Venous Leg Ulcers Treatment by Countries
      • 6.1.1 North America Venous Leg Ulcers Treatment Sales by Countries
      • 6.1.2 North America Venous Leg Ulcers Treatment Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Venous Leg Ulcers Treatment by Product
    • 6.3 North America Venous Leg Ulcers Treatment by End User

    7 Europe

    • 7.1 Europe Venous Leg Ulcers Treatment by Countries
      • 7.1.1 Europe Venous Leg Ulcers Treatment Sales by Countries
      • 7.1.2 Europe Venous Leg Ulcers Treatment Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Venous Leg Ulcers Treatment by Product
    • 7.3 Europe Venous Leg Ulcers Treatment by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Venous Leg Ulcers Treatment by Countries
      • 8.1.1 Asia Pacific Venous Leg Ulcers Treatment Sales by Countries
      • 8.1.2 Asia Pacific Venous Leg Ulcers Treatment Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Venous Leg Ulcers Treatment by Product
    • 8.3 Asia Pacific Venous Leg Ulcers Treatment by End User

    9 Central & South America

    • 9.1 Central & South America Venous Leg Ulcers Treatment by Countries
      • 9.1.1 Central & South America Venous Leg Ulcers Treatment Sales by Countries
      • 9.1.2 Central & South America Venous Leg Ulcers Treatment Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Venous Leg Ulcers Treatment by Product
    • 9.3 Central & South America Venous Leg Ulcers Treatment by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Venous Leg Ulcers Treatment by Countries
      • 10.1.1 Middle East and Africa Venous Leg Ulcers Treatment Sales by Countries
      • 10.1.2 Middle East and Africa Venous Leg Ulcers Treatment Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Venous Leg Ulcers Treatment by Product
    • 10.3 Middle East and Africa Venous Leg Ulcers Treatment by End User

    11 Company Profiles

    • 11.1 CardioVascular BioTherapeutics Inc
      • 11.1.1 CardioVascular BioTherapeutics Inc Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 CardioVascular BioTherapeutics Inc Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 CardioVascular BioTherapeutics Inc Venous Leg Ulcers Treatment Products Offered
      • 11.1.5 CardioVascular BioTherapeutics Inc Recent Development
    • 11.2 CytoTools AG
      • 11.2.1 CytoTools AG Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 CytoTools AG Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 CytoTools AG Venous Leg Ulcers Treatment Products Offered
      • 11.2.5 CytoTools AG Recent Development
    • 11.3 Daval International Ltd
      • 11.3.1 Daval International Ltd Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Daval International Ltd Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Daval International Ltd Venous Leg Ulcers Treatment Products Offered
      • 11.3.5 Daval International Ltd Recent Development
    • 11.4 Factor Therapeutics Ltd
      • 11.4.1 Factor Therapeutics Ltd Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Factor Therapeutics Ltd Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Factor Therapeutics Ltd Venous Leg Ulcers Treatment Products Offered
      • 11.4.5 Factor Therapeutics Ltd Recent Development
    • 11.5 FirstString Research Inc
      • 11.5.1 FirstString Research Inc Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 FirstString Research Inc Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 FirstString Research Inc Venous Leg Ulcers Treatment Products Offered
      • 11.5.5 FirstString Research Inc Recent Development
    • 11.6 GangaGen Inc
      • 11.6.1 GangaGen Inc Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 GangaGen Inc Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 GangaGen Inc Venous Leg Ulcers Treatment Products Offered
      • 11.6.5 GangaGen Inc Recent Development
    • 11.7 Hypo-Stream Ltd
      • 11.7.1 Hypo-Stream Ltd Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Hypo-Stream Ltd Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Hypo-Stream Ltd Venous Leg Ulcers Treatment Products Offered
      • 11.7.5 Hypo-Stream Ltd Recent Development
    • 11.8 Leap Therapeutics Inc
      • 11.8.1 Leap Therapeutics Inc Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Leap Therapeutics Inc Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Leap Therapeutics Inc Venous Leg Ulcers Treatment Products Offered
      • 11.8.5 Leap Therapeutics Inc Recent Development
    • 11.9 MediWound Ltd
      • 11.9.1 MediWound Ltd Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 MediWound Ltd Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 MediWound Ltd Venous Leg Ulcers Treatment Products Offered
      • 11.9.5 MediWound Ltd Recent Development
    • 11.10 NovaLead Pharma Pvt Ltd
      • 11.10.1 NovaLead Pharma Pvt Ltd Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 NovaLead Pharma Pvt Ltd Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 NovaLead Pharma Pvt Ltd Venous Leg Ulcers Treatment Products Offered
      • 11.10.5 NovaLead Pharma Pvt Ltd Recent Development
    • 11.11 Promore Pharma
    • 11.12 RegeneRx Biopharmaceuticals Inc
    • 11.13 RMB-Research GmbH
    • 11.14 Stratatech Corp

    12 Future Forecast

    • 12.1 Venous Leg Ulcers Treatment Market Forecast by Regions
      • 12.1.1 Global Venous Leg Ulcers Treatment Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Venous Leg Ulcers Treatment Revenue Forecast by Regions 2019-2025
    • 12.2 Venous Leg Ulcers Treatment Market Forecast by Product
      • 12.2.1 Global Venous Leg Ulcers Treatment Sales Forecast by Product 2019-2025
      • 12.2.2 Global Venous Leg Ulcers Treatment Revenue Forecast by Product 2019-2025
    • 12.3 Venous Leg Ulcers Treatment Market Forecast by End User
    • 12.4 North America Venous Leg Ulcers Treatment Forecast
    • 12.5 Europe Venous Leg Ulcers Treatment Forecast
    • 12.6 Asia Pacific Venous Leg Ulcers Treatment Forecast
    • 12.7 Central & South America Venous Leg Ulcers Treatment Forecast
    • 12.8 Middle East and Africa Venous Leg Ulcers Treatment Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Venous Leg Ulcers Treatment Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Venous Leg Ulcers Treatment market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Venous Leg Ulcers Treatment market based on company, product type, end user and key regions.

      This report studies the global market size of Venous Leg Ulcers Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Venous Leg Ulcers Treatment in these regions.
      This research report categorizes the global Venous Leg Ulcers Treatment market by top players/brands, region, type and end user. This report also studies the global Venous Leg Ulcers Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      CardioVascular BioTherapeutics Inc
      CytoTools AG
      Daval International Ltd
      Factor Therapeutics Ltd
      FirstString Research Inc
      GangaGen Inc
      Hypo-Stream Ltd
      Leap Therapeutics Inc
      MediWound Ltd
      NovaLead Pharma Pvt Ltd
      Promore Pharma
      RegeneRx Biopharmaceuticals Inc
      RMB-Research GmbH
      Stratatech Corp

      Market size by Product
      CureXcell
      CVBT-141B
      Granexin
      HP-802247
      Others
      Market size by End User
      Hospital
      Clinic
      Home Use

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Venous Leg Ulcers Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Venous Leg Ulcers Treatment market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Venous Leg Ulcers Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Venous Leg Ulcers Treatment submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Venous Leg Ulcers Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Venous Leg Ulcers Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now